Literature DB >> 19619902

Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.

Abayomi O Akanji1, Jude U Ohaeri, Suhail Al-Shammri, Hasmukh R Fatania.   

Abstract

Schizophrenia may be associated with inflammatory reactions and C-reactive protein (CRP) is a nonspecific serum protein marker for persisting inflammatory states. This study aimed to assess concentrations of high sensitivity CRP (hsCRP) in schizophrenic Arab patients and evaluate the relationships of hsCRP levels with aspects of clinical phenotypes of the disease. Two age-matched groups of subjects were studied: (1) healthy controls, HC, n=165; (2) patients with schizophrenia, SZ: n=207. Each subject was evaluated with a standard questionnaire for age at disease onset, family history, disease severity and outcome. Serum hsCRP levels were measured by immunoassay. The two groups of subjects were similar in age, ethnic composition and socioeconomic status. Those with SZ had significantly greater serum concentrations of hsCRP. There were significant associations between hsCRP and (i) age in both groups; (ii) body mass index (BMI) in HC but not in SZ. In the latter, hsCRP levels were: (a) marginally higher in women with later age of disease onset; (ii) highest with remission and with catatonic features; and (iii) lower with family history of psychosis. The study concludes that serum levels of hsCRP are increased in clinically stable Arab patients with schizophrenia and appear related to the disorder's clinical expression. It is suggested that there may be an inflammatory component to schizophrenia which is associated with aspects of its clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619902     DOI: 10.1016/j.psychres.2008.06.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

1.  Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychiatry Res       Date:  2012-03-08       Impact factor: 3.222

2.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 3.  Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?

Authors:  Jeanne E Maglione; Scot E Thomas; Dilip V Jeste
Journal:  Curr Opin Psychiatry       Date:  2014-05       Impact factor: 4.741

4.  Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia.

Authors:  Ted Boozalis; Sridevi Devaraj; Olaoluwa O Okusaga
Journal:  Psychiatr Q       Date:  2019-03

5.  Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medications.

Authors:  Sun H Kim; Gerald Reaven; Steven Lindley
Journal:  Int Clin Psychopharmacol       Date:  2011-01       Impact factor: 1.659

6.  C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

Authors:  B S Fernandes; J Steiner; H-G Bernstein; S Dodd; J A Pasco; O M Dean; P Nardin; C-A Gonçalves; M Berk
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

7.  Catatonic schizophrenia: a cohort prospective study.

Authors:  Karine Kleinhaus; Susan Harlap; Mary C Perrin; Orly Manor; Mark Weiser; Jill M Harkavy-Friedman; Pesach Lichtenberg; Dolores Malaspina
Journal:  Schizophr Bull       Date:  2010-08-06       Impact factor: 9.306

8.  Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.

Authors:  Jamie Joseph; Colin Depp; Averria Sirkin Martin; Rebecca E Daly; Danielle K Glorioso; Barton W Palmer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2015-09-02       Impact factor: 4.939

9.  A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.

Authors:  Nicolas Hoertel; Léa Rotenberg; Carlos Blanco; Vincent Camus; Caroline Dubertret; Véronique Charlot; Franck Schürhoff; Pierre Vandel; Frédéric Limosin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-15       Impact factor: 4.328

10.  Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study.

Authors:  M Faugere; J A Micoulaud-Franchi; M Alessandrini; R Richieri; C Faget-Agius; P Auquier; C Lançon; L Boyer
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.